Evidence map›Paper›PMID 28811960›Full record

ArticleOncoimmunology

Li Xu, Minseok Kwak, Wei Zhang, Ling Zeng, Peter Chang-Whan Lee, Jun-O Jin

Open access · goldAbstract read
In one paragraph

Article in Oncoimmunology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 52 citations in OpenAlex.

  1. Frontiers in nutrition · 2026
    Review
  2. Review
  3. Review
  4. Review
  5. Research Progress on the Anticancer Activity of Plant Polysaccharides.Recent patents on anti-cancer drug discovery · 2024
    Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. A Meta-Analysis of Randomized Clinical Trials of Runzao Zhiyang Capsule in Chronic Urticaria.Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
  11. Review
  12. Molecular therapy oncolytics · 2021
    Article
  13. Intranasal Administration ofInternational journal of molecular sciences · 2021
    Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Polysaccharide fromMarine drugs · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Li XuShanghai Public Health Clinical Center, Shanghai Medical College, Fudan University, Shanghai, China.
Minseok KwakDepartment of Chemistry, Pukyong National University, Busan, South Korea.
Wei ZhangShanghai Public Health Clinical Center, Shanghai Medical College, Fudan University, Shanghai, China.
Ling ZengShanghai Public Health Clinical Center, Shanghai Medical College, Fudan University, Shanghai, China.
Peter Chang-Whan LeeDepartment of Biomedical Sciences, University of Ulsan College of Medicine, ASAN Medical Center, Seoul, South Korea.
Jun-O JinShanghai Public Health Clinical Center, Shanghai Medical College, Fudan University, Shanghai, China.
Shanghai Public Health Clinical Center · CNPukyong National University · KRUlsan College · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Adjuvantanticancerdendritic cell maturationRehmannia glutinosa polysaccharideTLR4

Identifiers

PMID28811960
PMCPMC5543824
OpenAlexW2613163591

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.